Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
about
Toxoplasmosis--a global threat. Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countriesNeglected parasitic infections in the United States: toxoplasmosisToxoplasma gondii: 1908-2008, homage to Nicolle, Manceaux and SplendoreToxoplasma gondii-altered host behaviour: clues as to mechanism of actionToxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour?Toxoplasma gondii infection and behaviour - location, location, location?Toxoplasma gondii seropositivity and suicide rates in womenToxoplasma gondii and other risk factors for schizophrenia: an updateSchizophrenia and toxoplasmosisEffects of Toxoplasma gondii infection on the brainA review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesisWorld Health Organization Estimates of the Global and Regional Disease Burden of 11 Foodborne Parasitic Diseases, 2010: A Data SynthesisClinically Available Medicines Demonstrating Anti-Toxoplasma ActivityThe cytokine model of schizophrenia: emerging therapeutic strategiesDrug repurposing and human parasitic protozoan diseasesInterferon-gamma- and perforin-mediated immune responses for resistance against Toxoplasma gondii in the brainToxoplasma gondii-induced neuronal alterationsAutoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feelingMeta-Analysis of Anti-Toxoplasma gondii IgM Antibodies in Acute PsychosisToxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological DisordersFatal attraction phenomenon in humans: cat odour attractiveness increased for toxoplasma-infected men while decreased for infected womenChronic Toxoplasma gondii in Nurr1-null heterozygous mice exacerbates elevated open field activitySeropositivity and serointensity of Toxoplasma gondii antibodies and DNA among patients with schizophreniaInflammation and the two-hit hypothesis of schizophrenia.Contrasting effect of prepulse signals on performance of Toxoplasma-infected and Toxoplasma-free subjects in an acoustic reaction times test.Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controlsThe environment and susceptibility to schizophrenia.A classification of sociomedical health indicators: perspectives for health administrators and health planners.Neurological and behavioral abnormalities, ventricular dilatation, altered cellular functions, inflammation, and neuronal injury in brains of mice due to common, persistent, parasitic infection.Genetic diversity of Toxoplasma gondii in animals and humans.Understanding Toxoplasmosis in the United States Through "Large Data" AnalysesThe evolutionary puzzle of suicide.Seroepidemiology of human Toxoplasma gondii infection in China.Investigation of anti-Toxocara and anti-toxoplasma antibodies in patients with schizophrenia disorder.Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies.Toxoplasma gondii seroprevalence in the United States 2009-2010 and comparison with the past two decades.Removal of Toxoplasma gondii cysts from the brain by perforin-mediated activity of CD8+ T cells.Analysis of peripheral immune activation in schizophrenia using quantitative reverse-transcription polymerase chain reaction (RT-PCR)Diagnosis of Swine Toxoplasmosis by PCR and Genotyping of Toxoplasma gondii from pigs in Henan, Central China.Neurophysiological Changes Induced by Chronic Toxoplasma gondii Infection
P2860
Q21090649-F2D4322E-B14D-475E-8C90-943D98D637F7Q22305416-6152C626-7A7A-4988-93B7-FAF682DED274Q22305914-BBB22A26-35E9-4EF4-99DC-79528014BD88Q22306047-6972D3E5-3896-41B9-9A39-270E128A29E4Q22306157-60AD37A5-DB47-4B10-ACB8-BC599A3FD260Q22306158-6689ADE3-8492-4C5C-BD66-A4D70D3A8A01Q24599367-240AF440-8318-4ACE-AFF9-C3D7A1240B22Q24634447-FA7F4FEB-5466-4D9C-9E98-11DDBD0D59FBQ24656952-5169A021-84A1-4F1B-A9C5-6AF97EC483F2Q24656964-1A6B4AD7-6597-40F8-A244-ADA74464474CQ26748778-85E2492C-B796-4A64-B1CA-A4CE89CA2D50Q26774963-742D8BCE-D20B-4764-9A60-9425BAF7A593Q26782581-E0997139-BE5F-44E9-AED7-F4B771D0FF68Q26865996-B0276D62-F763-4C89-B80E-E0F3878F79C6Q26999453-AAC0AAE1-5C71-472D-9CCC-588CE1CAA4D3Q27011746-F5AA8B0E-7722-4203-B369-EB931262527EQ27027025-F5D633C6-E6D8-471C-B804-0CD0C3A7BB56Q28244133-791B15F9-ACAA-4E4B-9BA0-1B2386BB15AAQ28648499-9CB6CD08-923E-4651-BCD3-3BCEC1AFDCFDQ28709645-B201AE0A-CB13-4ADF-AB48-2DC9CC4DBAF5Q28743032-8DB4A1B6-8EE5-49AC-8CA7-A476F4E9AB95Q30413968-D86622AF-29DB-4808-95D3-A55D4594A01CQ30414564-C5CC4821-082F-45A5-AD17-9EA0F1037F35Q30422062-1E0C9C04-E578-4CD4-B790-5F676769C10AQ30426286-ABC9A3B0-1084-471E-AEC0-41A3AB3D4FE8Q30430004-893C835A-9B39-4B36-A7F5-D2F0A4D095DFQ30459929-8BEC3D5A-F313-4277-8BA7-D814F9F64447Q30478069-F4812675-5E11-478F-85B1-D147919E42EBQ30484779-B022448D-47DD-42A2-A037-3B3A2453CDDFQ31080457-7C9E189E-A1BA-4359-9F03-9F6A574657F7Q31111181-13EB6E0A-BD93-40B6-8C1C-F55BA4D9206DQ33357391-4943A042-6349-417E-A764-0B810D374778Q33522475-7336F833-4B08-4D7C-BD01-844EB685C350Q33562920-4F367F7C-E718-4F64-AB6D-74AF47F78875Q33601896-33D23CCB-C0C5-473A-A0C0-AC541580FD92Q33719625-B19CA167-C880-440E-B260-89B2E03F1319Q33745093-303BDC11-D855-45EA-9F42-03C156E27A67Q33749249-B1350502-9435-424F-B685-C3A57270EDD6Q33750140-C509712B-5D0A-4AF9-A714-0B5825CFABF4Q33847259-6E2AD05E-16FF-49E7-A29C-61A5CAF108DE
P2860
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
description
2007 nî lūn-bûn
@nan
2007 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@ast
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@en
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@nl
type
label
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@ast
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@en
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@nl
prefLabel
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@ast
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@en
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@nl
P2093
P2860
P921
P3181
P356
P1476
Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis
@en
P2093
E Fuller Torrey
John J Bartko
Robert H Yolken
Zhao-Rong Lun
P2860
P304
P3181
P356
10.1093/SCHBUL/SBL050
P407
P577
2007-05-01T00:00:00Z